Table 1.
Clinical and biochemical factors in the total study sample, participants without metabolic syndrome and participants with metabolic syndrome
| IDF (n, %) | AHA/NHLBI (n, %) | ||||
|---|---|---|---|---|---|
| All | no MetS (178, 63) | MetS (106, 37) | no MetS (189, 67) | MetS (95, 33) | |
| Age (years) | 52.00 (46.00, 59.88) | 51.00 (45.00, 56.00) | 56.50 (49.00, 62.25)b | 51.00 (45.00, 56.50) | 56.00 (49.00, 62.00)b |
| Sex (men, women), n (%) | 159 (56)/ 125(44) | 85 (48)/ 93 (52) | 74 (70)/ 32 (30)a | 93 (49)/ 96 (51) | 66 (69)/ 29 (31)a |
| HDL-cholesterol (mmol/L) | 1.29 (1.08, 1.51) | 1.38 (1.21, 1.58) | 1.09 (0.94, 1.29)b | 1.38 (1.20, 1.58) | 1.08 (0.94, 1.25)b |
| LDL-cholesterol (mmol/L) | 3.43 (2.91, 4.04) | 3.46 (2.97, 4.06) | 3.30 (2.73, 3.92) | 3.45 (2.94, 3.95) | 3.38 (2.90, 4.10) |
| Triglycerides (mmol/L) | 1.15 (0.86, 1.62) | 1.05 (0.76, 1.30) | 1.61 (1.14, 2.18)b | 1.05 (0.77, 1.30) | 1.70 (1.13, 2.33)b |
| Glucose (mmol/L) | 4.99 (4.72, 5.35) | 4.90 (4.69, 5.17) | 5.22 (4.86, 5.71)b | 4.90 (4.68, 5.17) | 5.24 (4.90, 5.82)b |
| Insulin (mU/L) | 8.20 (5.80, 11.85) | 6.80 (4.90, 9.20) | 11.30 (8.65, 14.00)b | 6.80 (5.00, 9.05) | 11.80 (9.10, 14.87)b |
| Medical treatment for: | |||||
| Hypertension (no/yes), n (%) | 213 (75)/ 49 (17.3) | 152 (85.4)/ 14 (7.9) | 61 (57.5)/ 35 (33)a | 155 (82)/ 20 (10.6) | 58 (61.1)/ 29 (30.5)a |
| Hypercholesterolemia (no/yes), n (%) | 161 (56.7)/ 109 (38.4) | 118 (66.3)/ 52 (29.2) | 43 (40.6)/ 57 (53.8)a | 122 (64.6)/ 57 (30.2) | 39 (41.1)/ 52 (54.7)a |
| Type 2 diabetes mellitus (no/yes), n (%) | 250 (88)/ 14 (4.9) | 165 (92.7)/ 2 (1.1) | 85 (80.2)/ 12 (11.3)a | 175 (92.6)/ 2 (1.1) | 75 (78.9)/ 12 (12.6)a |
| SBP (mmHg) | 123.00 (114.00, 133.50) | 118.00 (109.75, 127.00) | 133.00 (124.75, 138.00)b | 118.50 (110.00, 128.00) | 133.00 (125.25, 138.00)b |
| DBP (mmHg) | 79.00 (70.00, 86.00) | 75.25 (69.00, 82.40) | 84.00 (77.00, 90.00)b | 76.00 (69.00, 83.00) | 85.00 (77.00, 90.00)b |
| BMI (kg/m2) | 27.25 (24.73, 31.00) | 25.40 (23.90, 29.00) | 29.80 (27.20, 32.40)b | 25.70 (23.95, 28.85) | 30.00 (28.00, 32.70)b |
| Waist circumference (cm) | 96.00 (86.00, 106.00) | 90.00 (81.25, 98.88) | 103.00 (97.75, 111.25)b | 90.00 (82.00, 99.00) | 105.00 (98.00, 112.00)b |
| IL-6 plasma concentration (pg/mL) | 1.621 (0.983, 2.696) | 1.392 (0.897, 2.209) | 2.152 (1.274, 3.026)b | 1.394 (0.897, 2.329) | 2.099 (1.391, 3.036)b |
| Adiponectin plasma concentration (μg/mL) | 7.419 (4.763, 10.516) | 8.471 (5.883, 12.944) | 5.546 (3.799, 8.693)b | 8.473 (5.680, 12.579) | 5.476 (4.072, 8.454)b |
Quantitative variables are expressed as median (25th, 75th IQR)
aPearson Chi-Square, P ≤ 0.001 for comparison between no MetS and MetS separately for two definitions of MetS
bKolmogorov-Smirnov Z Test, P ≤ 0.001 for comparison between no MetS and MetS separately for two definitions of MetS